PACIFIC Archives - Medical Conferences

Durvalumab after sequential CRT safe in stage III, unresectable NSCLC

Presented By

Dr Marina Garassino, University of Chicago, IL, USA

Trial

Phase 2, PACIFIC-6

Conference

ELCC 2022

25 May, 2022 12:37

No impact of grade ≥2 pneumonitis on patient-reported outcomes in PACIFIC

Presented By

Prof. Rina Hui, University of Sydney, Australia

Trial

Phase 3, PACIFIC

Conference

ELCC 2022

25 May, 2022 12:37

5-year PACIFIC data hold strong in NSCLC

Presented By

Dr. Camille Hertzka, AstraZeneca

Trial

Phase 3, PACIFIC

Journal

Physician's Weekly

Conference

ASCO 2021

6 August, 2021 12:05

Overcoming the challenges of immunotherapy in non–small cell lung cancer

Presented By

Dr Sarah B. Goldberg, Dr Melissa Lynne Johnson, Dr Alexander Chi

Trial

PACIFIC, KEYNOTE-024, KEYNOTE-189

Conference

ASCO 2019

15 July, 2019 22:04

Post-discontinuation immunotherapy in PACIFIC

Presented By

Dr Phillip Dennis, Dr Marina Garassino

Trial

Phase 3, PACIFIC

Conference

ELCC 2019

25 June, 2019 23:23

Durvalumab after chemoradiotherapy extends OS in stage 3, unresectable non-small-cell lung cancer

Presented By

Dr Scott Antonia, H. Lee Moffitt Cancer Center and Research Institute, USA

Trial

Phase 3, PACIFIC

Conference

WCLC 2018

21 November, 2018 23:28

Next generation immunotherapy in non-small-cell lung cancer

Presented By

Prof. Solange Peters, Lausanne University Hospital and Ludwig Institute, Switzerland

Conference

WCLC 2018

21 November, 2018 23:02

Interview with the IASCL President, Dr. Giorgio Scagliotti

Expert

Dr. Giorgio Scagliotti, University of Torino, Italy

Conference

WCLC 2018

21 November, 2018 21:24